A COMPREHENSIVE STUDY OF RECENT BREAKTHROUGHS IN THE MANAGEMENT OF DYNAMIC VIRAL INFECTIONS

ROMA SHARMA; SURABHI SINGH

doi:10.22159/ijcpr.2023v15i6.3099

Authors

ROMA SHARMA School of Basic and Applied Science, Career Point University, Kota India
SURABHI SINGH School of Basic and Applied Science, Career Point University, Kota India

DOI:

https://doi.org/10.22159/ijcpr.2023v15i6.3099

Keywords:

Virus, Infections, Novel technologies, Resistance, Pandemic, Virology

Abstract

Infectious diseases have been known to human civilization since the dawn of humanity. Infectious disorders are caused by various microorganisms (bacteria, fungi, and viruses). Viruses are the most well-known of all microbes. Viruses are the most well-known type of microbe. They are ultramicroscopic intracellular parasites that require a host cell to survive and reproduce. Viruses have either DNA or RNA as genetic material and have been linked to various diseases in humans, animals, and plants. The war between viruses and humans is ongoing, as both will employ diverse ways to oppose each other. Antiviral treatment and improved technology development a time-consuming process. Despite advanced instruments and tight quality control systems, only a few numbers of antiviral medications or treatment technologies are approved for human use. The cause could be side effects or antiviral medication resistance. Increased understanding of viruses, their infection mechanisms, and the rapid evolution of novel antiviral methods and methodologies will accelerate the creation of novel antiviral medications. This review focuses on the worldwide picture of drug discovery for infectious diseases and contemporary improved methodologies and antiviral therapy options.

Downloads

Download data is not yet available.

References

Wu Y, Zou J, Sun Yinfu, Xiang Q, He M, Zhang S. Global infectious diseases in Apr 2023: monthly analysis. Zoonoses. 2023;3(1):1-17. doi: 10.15212/zoonoses-2023-1005.

Meganck RM, Baric RS. Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases. Nat Med. 2021;27(3):401-10. doi: 10.1038/s41591-021-01282-0, PMID 33723456.

Menachery VD, Yount BL Jr, Sims AC, Debbink K, Agnihothram SS, Gralinski LE. SARS-like WIV1-CoV poised for human emergence. Proc Natl Acad Sci USA. 2016;113(11):3048-53. doi: 10.1073/pnas.1517719113, PMID 26976607.

Sheahan TP, Sims AC, Graham RL, Menachery VD, Gralinski LE, Case JB. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med. 2017;9(396):eaal3653. doi: 10.1126/scitranslmed.aal3653, PMID 28659436.

Edwards CE, Yount BL, Graham RL, Leist SR, Hou YJ, Dinnon KH. Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection. Proc Natl Acad Sci USA. 2020;117(43):26915-25. doi: 10.1073/pnas.2001046117, PMID 33046644.

Sharif Yakan A, Kanj SS. Emergence of MERS-CoV in the Middle East: origins, transmission, treatment, and perspectives. PLOS Pathog. 2014;10(12):e1004457. doi: 10.1371/journal.ppat.1004457, PMID 25474536.

Simmonds P. Reconstructing the origins of human hepatitis viruses. Philos Trans R Soc Lond B Biol Sci. 2001;356(1411):1013-26. doi: 10.1098/rstb.2001.0890, PMID 11516379.

Kitchen A, Shackelton LA, Holmes EC. Family-level phylogenies reveal modes of macroevolution in RNA viruses. Proc Natl Acad Sci USA. 2011;108(1):238-43. doi: 10.1073/pnas.1011090108, PMID 21173251.

Wolfe ND, Dunavan CP, Diamond J. Origins of major human infectious diseases. Nature. 2007;447(7142):279-83. doi: 10.1038/nature05775, PMID 17507975.

Plourde AR, Bloch EM. A literature review of Zika virus. Emerg Infect Dis. 2016;22(7):1185-92. doi: 10.3201/eid2207.151990, PMID 27070380.

Shukla P, Nguyen HT, Torian U, Engle RE, Faulk K, Dalton HR. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc Natl Acad Sci USA. 2011;108(6):2438-43. doi: 10.1073/pnas.1018878108, PMID 21262830.

Grenfell BT, Pybus OG, Gog JR, Wood JL, Daly JM, Mumford JA. Unifying the epidemiological and evolutionary dynamics of pathogens. Science. 2004;303(5656):327-32. doi: 10.1126/science.1090727, PMID 14726583.

Lam TT, Zhu H, Guan Y, Holmes EC. Genomic analysis of the emergence, evolution, and spread of human respiratory RNA viruses. Annu Rev Genomics Hum Genet. 2016;17:193-218. doi: 10.1146/annurev-genom-083115-022628, PMID 27216777.

Krause RM. The origin of plagues: old and new. Science. 1992;257(5073):1073-8. doi: 10.1126/science.257.5073.1073, PMID 1509258.

Wever PC, van Bergen L. Death from 1918 pandemic influenza during the First World War: a perspective from personal and anecdotal evidence. Influenza Other Respir Viruses. 2014;8(5):538-46. doi: 10.1111/irv.12267, PMID 24975798.

Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis. 2012;12(9):687-95. doi: 10.1016/S1473-3099(12)70121-4, PMID 22738893.

Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet. 1971;1(7712):1253-7. doi: 10.1016/s0140-6736(71)91776-4, PMID 4104714.

Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. Cultivation of approval-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet. 1971;1(7712):1257-60. doi: 10.1016/s0140-6736(71)91777-6, PMID 4104715.

Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096-100. doi: 10.1126/science.1152586, PMID 18202256.

Paweska JT, Sewlall NH, Ksiazek TG, Blumberg LH, Hale MJ, Lipkin WI. Nosocomial outbreak of novel arenavirus infection, southern Africa. Emerg Infect Dis. 2009;15(10):1598-602. doi: 10.3201/eid1510.090211, PMID 19861052.

Lu S, Xi X, Zheng Y, Cao Y, Liu X, Lu H. Analysis of the clinical characteristics and treatment of two patients with avian influenza virus (H7N9). BioSci Trends. 2013;7(2):109-12. doi: 10.5582/bst.2013.v7.2.109, PMID 23612081.

Khan G. A novel coronavirus capable of lethal human infections: an emerging picture. Virol J. 2013;10:66. doi: 10.1186/1743-422X-10-66, PMID 23445530.

Musso D, Gubler DJ. Zika Virus. Clin Microbiol Rev. 2016;29(3):487-524. doi: 10.1128/CMR.00072-15, PMID 27029595.

Cherry JD. The chronology of the 2002-2003 SARS mini pandemic. Paediatr Respir Rev. 2004;5(4):262-9. doi: 10.1016/j.prrv.2004.07.009, PMID 15531249.

Luo CM, Wang N, Yang XL, Liu HZ, Zhang W, Li B. Discovery of novel bat coronaviruses in South China that use the same receptor as Middle East respiratory syndrome coronavirus. J Virol. 2018;92(13):e00116-18. doi: 10.1128/JVI.00116-18, PMID 29669833.

Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 2002;10(2):100-3. doi: 10.1016/s0966-842x(01)02288-0, PMID 11827812.

Thomas SJ, Yoon IK. A review of Dengvaxia®: development to deployment. Hum Vaccin Immunother. 2019;15(10):2295-314. doi: 10.1080/21645515.2019.1658503, PMID 31589551.

Osterholm MT, Moore KA, Kelley NS, Brosseau LM, Wong G, Murphy FA. Transmission of ebolaviruses: what we know and what we do not know. mBio. 2015;6(4):e01154. doi: 10.1128/mBio.01154-15, PMID 26199336.

Nachbagauer R, Feser J, Naficy A, Bernstein DI, Guptill J, Walter EB. A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial. Nat Med. 2021;27(1):106-14. doi: 10.1038/s41591-020-1118-7, PMID 33288923.

Ilunga Kalenga O, Moeti M, Sparrow A, Nguyen VK, Lucey D, Ghebreyesus TA. The ongoing ebola epidemic in the democratic republic of Congo, 2018-2019. N Engl J Med. 2019;381(4):373-83. doi: 10.1056/NEJMsr1904253, PMID 31141654.

Neumann G, Chen H, Gao GF, Shu Y, Kawaoka Y. H5N1 influenza viruses: outbreaks and biological properties. Cell Res. 2010;20(1):51-61. doi: 10.1038/cr.2009.124, PMID 19884910.

Burt FJ, Chen W, Miner JJ, Lenschow DJ, Merits A, Schnettler E. Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. Lancet Infect Dis. 2017;17(4):e107-17. doi: 10.1016/S1473-3099(16)30385-1, PMID 28159534.

Forrester NL, Wertheim JO, Dugan VG, Auguste AJ, Lin D, Adams AP. Evolution and spread of Venezuelan equine encephalitis complex Alphavirus in the Americas. PLOS Negl Trop Dis. 2017;11(8):e0005693. doi: 10.1371/journal.pntd.0005693, PMID 28771475.

Chhabra P, de Graaf M, Parra GI, Chan MC, Green K, Martella V. Updated classification of norovirus genogroups and genotypes. J Gen Virol. 2019;100(10):1393-406. doi: 10.1099/jgv.0.001318, PMID 31483239.

De Graaf M, van Beek J, Koopmans MP. Human norovirus transmission and evolution in a changing world. Nat Rev Microbiol. 2016;14(7):421-33. doi: 10.1038/nrmicro.2016.48, PMID 27211790.

Chilamakuri R, Agarwal S. COVID-19: characteristics and therapeutics. Cells. 2021;10(2):206. doi: 10.3390/cells10020206, PMID 33494237.

Song Y, Fang Z, Zhan P, Liu X. Recent advances in the discovery and development of novel HIV-1 NNRTI platforms (Part II): 2009-2013 update. Curr Med Chem. 2014;21(3):329-55. doi: 10.2174/09298673113206660298, PMID 24164196.

Xia X. Bioinformatics and drug discovery. Curr Top Med Chem. 2017;17(15):1709-26. doi: 10.2174/1568026617666161116143440, PMID 27848897.

Xie X, Rigor P, Baldi P. Motif Map: a human genome-wide map of candidate regulatory motif sites. Bioinformatics. 2009;25(2):167-74. doi: 10.1093/bioinformatics/btn605, PMID 19017655.

Joon S, Singla RK, Shen B. In silico drug discovery for treatment of virus diseases. Adv Exp Med Biol. 2022;1368:73-93. doi: 10.1007/978-981-16-8969-7_4, PMID 35594021.

Murgueitio MS, Bermudez M, Mortier J, Wolber G. In silico virtual screening approaches for anti-viral drug discovery. Drug Discov Today Technol. 2012;9(3):e219-25. doi: 10.1016/j.ddtec.2012.07.009, PMID 24990575.

Ali W, Benedetti R, Handzlik J, Zwergel C, Battistelli C. The innovative potential of selenium-containing agents for fighting cancer and viral infections. Drug Discov Today. 2021;26(1):256-63. doi: 10.1016/j.drudis.2020.10.014, PMID 33164821.

Bae M, Kim H. Mini-review on the roles of vitamin C, vitamin D, and selenium in the immune system against COVID-19. Molecules. 2020;25(22):5346. doi: 10.3390/molecules25225346, PMID 33207753.

Faghfuri E, Yazdi MH, Mahdavi M, Sepehrizadeh Z, Faramarzi MA, Mavandadnejad F. Dose-response relationship study of selenium nanoparticles as an immunostimulatory agent in cancer-bearing mice. Arch Med Res. 2015;46(1):31-7. doi: 10.1016/j.arcmed.2015.01.002, PMID 25604604.

Wu Z, Ma G, Zhu H, Chen M, Huang M, Xie X. Plant viral coat proteins as biochemical targets for antiviral compounds. J Agric Food Chem. 2022;70(29):8892-900. doi: 10.1021/acs.jafc.2c02888, PMID 35830295.

Costales MG, Matsumoto Y, Velagapudi SP, Disney MD. Small molecule targeted recruitment of a nuclease to RNA. J Am Chem Soc. 2018;140(22):6741-4. doi: 10.1021/jacs.8b01233, PMID 29792692.

Costales MG, Suresh B, Vishnu K, Disney MD. Targeted degradation of a hypoxia-associated non-coding RNA enhances the selectivity of a small molecule interacting with RNA. Cell Chem Biol. 2019;26(8):1180-1186.e5. doi: 10.1016/j.chembiol.2019.04.008, PMID 31130520.

Lai AC, Crews CM. Induced protein degradation: an emerging drug discovery paradigm. Nat Rev Drug Discov. 2017;16(2):101-14. doi: 10.1038/nrd.2016.211, PMID 27885283.

Paiva SL, Crews CM. Targeted protein degradation: elements of protac design. Curr Opin Chem Biol. 2019;50:111-9. doi: 10.1016/j.cbpa.2019.02.022, PMID 31004963.

Nie C, Stadtmüller M, Yang H, Xia Y, Wolff T, Cheng C. Spiky nanostructures with geometry-matching topography for virus inhibition. Nano Lett. 2020;20(7):5367-75. doi: 10.1021/acs.nanolett.0c01723, PMID 32515974.

Aguilera Correa JJ, Esteban J, Vallet Regi M. Inorganic and polymeric nanoparticles for human viral and bacterial infections prevention and treatment. Nanomaterials (Basel). 2021;11(1):137. doi: 10.3390/nano11010137, PMID 33435597.

Hendy DA, Amouzougan EA, Young IC, Bachelder EM, Ainslie KM. Nano/microparticle formulations for universal influenza vaccines. AAPS J. 2022;24(1):24. doi: 10.1208/s12248-021-00676-9, PMID 34997352.

Abozaid D, Ramadan A, Barakat H, Khalafallah N. Acyclovir lipid nanocapsules gel for oromucosal delivery: preclinical evidence of efficacy in the chicken pouch membrane model. Eur J Pharm Sci. 2018;121:228-35. doi: 10.1016/j.ejps.2018.05.016, PMID 29778782.

Dou H, Grotepas CB, McMillan JM, Destache CJ, Chaubal M, Werling J. Macrophage delivery of nano formulated antiretroviral drug to the brain in a murine model of neuroAIDS. J Immunol. 2009;183(1):661-9. doi: 10.4049/jimmunol.0900274, PMID 19535632.

Huang HS, Tsai CL, Chang J, Hsu TC, Lin S, Lee CC. Multiplex PCR system for the rapid diagnosis of respiratory virus infection: systematic review and meta-analysis. Clin Microbiol Infect. 2018;24(10):1055-63. doi: 10.1016/j.cmi.2017.11.018, PMID 29208560.

Yan Y, Liu XY, Lu A, Wang XY, Jiang LX, Wang JC. Non-viral vectors for RNA delivery. J Control Release. 2022;342:241-79. doi: 10.1016/j.jconrel.2022.01.008, PMID 35016918.

Falanga A, Del Genio V, Galdiero S. Peptides and dendrimers: how to combat viral and bacterial infections. Pharmaceutics. 2021;13(1):101. doi: 10.3390/pharmaceutics13010101, PMID 33466852.

Maduray K, Parboosing R. Metal nanoparticles: a promising treatment for viral and arboviral infections. Biol Trace Elem Res. 2021;199(8):3159-76. doi: 10.1007/s12011-020-02414-2, PMID 33029761.

Aggarwal N, Sachin, Nabi B, Aggarwal S, Baboota S, Ali J. Nano-based drug delivery system: a smart alternative towards eradication of viral sanctuaries in management of NeuroAIDS. Drug Deliv Transl Res. 2022;12(1):27-48. doi: 10.1007/s13346-021-00907-8, PMID 33486689.

A COMPREHENSIVE STUDY OF RECENT BREAKTHROUGHS IN THE MANAGEMENT OF DYNAMIC VIRAL INFECTIONS

Authors

DOI:

Keywords:

Abstract

Downloads

References

Published

How to Cite

Issue

Section